BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28596226)

  • 1. Autoimmune hemolytic anemia associated with trimethoprim-sulfamethoxazole use.
    Frieder J; Mouabbi JA; Zein R; Hadid T
    Am J Health Syst Pharm; 2017 Jun; 74(12):894-897. PubMed ID: 28596226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible Trimethoprim-Sulfamethoxazole-Induced Hemolytic Anemia: A Case Report.
    Williams MF; Doss EP; Montgomery M
    J Pharm Pract; 2017 Dec; 30(6):653-657. PubMed ID: 29121838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
    Chisholm-Burns MA; Patanwala AE; Spivey CA
    Am J Health Syst Pharm; 2010 Jan; 67(2):123-7. PubMed ID: 20065266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
    Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
    Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-induced immune hemolytic anemia in a pediatric oncology patient presenting as an acute hemolytic transfusion reaction.
    Gupta S; Piefer CL; Fueger JT; Johnson ST; Punzalan RC
    Pediatr Blood Cancer; 2010 Dec; 55(6):1201-3. PubMed ID: 20589632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.
    Linnik YA; Tsui EW; Martin IW; Szczepiorkowski ZM; Denomme GA; Gottschall JL; Hill JM; Dunbar NM
    Transfusion; 2017 Dec; 57(12):2937-2941. PubMed ID: 28905389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
    Alappan R; Perazella MA; Buller GK
    Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.
    Johnson ST; Fueger JT; Gottschall JL
    Transfusion; 2007 Apr; 47(4):697-702. PubMed ID: 17381629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
    Lou C; Liu M; Ma T; Yang L; Long D; Li J; Lei H; Xiang D; Wang X; Li L; Cai X
    Front Immunol; 2024; 15():1390082. PubMed ID: 38756782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemolytic anaemia and renal failure associated with antibodies to trimethoprim and sulfamethoxazole.
    Arndt PA; Garratty G; Wolf CF; Rivera M
    Transfus Med; 2011 Jun; 21(3):194-8. PubMed ID: 21175904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use.
    Ermis B; Caner I; Karacan M; Olgun H
    Thromb Haemost; 2003 Jul; 90(1):158-9. PubMed ID: 12876641
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced immune hemolytic anemia.
    Garratty G
    Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced immune hemolytic anemia: the last 30 years of changes.
    Arndt PA
    Immunohematology; 2014; 30(2):44-54. PubMed ID: 25247622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute autoimmune hemolytic anemia due to anti-En
    Nedelcu E; Desai M; Green J; Bensing KM; Turner A; Head D; Young PP
    Transfusion; 2018 Jan; 58(1):176-180. PubMed ID: 29023757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.
    Antoniou T; Hollands S; Macdonald EM; Gomes T; Mamdani MM; Juurlink DN;
    CMAJ; 2015 Mar; 187(4):E138-E143. PubMed ID: 25646289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual case of autoimmune hemolytic anemia with reticulocytopenia, erythroid dysplasia, and an IgG2 autoanti-U.
    Roush GR; Rosenthal NS; Gerson SL; Toy EM; McCarthy P; Hirschler NV; Yomtovian R
    Transfusion; 1996 Jun; 36(6):575-80. PubMed ID: 8669092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and reference lab characteristics of patients with suspected direct antiglobulin test (DAT)-negative immune hemolytic anemia.
    Karafin MS; Denomme GA; Schanen M; Gottschall JL
    Immunohematology; 2015; 31(3):108-15. PubMed ID: 26829176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible voltage-dependent distal renal tubular acidosis in a patient receiving standard doses of trimethoprim-sulphamethoxazole.
    Lin SH; Kuo AA; Yu FC; Lin YF
    Nephrol Dial Transplant; 1997 May; 12(5):1031-3. PubMed ID: 9175064
    [No Abstract]   [Full Text] [Related]  

  • 19. Automatic laboratory-initiated reflex testing to identify patients with autoimmune hemolytic anemia.
    Froom P; Neck A; Shir M; Haavis R; Barak M
    Am J Clin Pathol; 2005 Jul; 124(1):129-32. PubMed ID: 15923165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct antiglobulin ("Coombs") test-negative autoimmune hemolytic anemia: a review.
    Segel GB; Lichtman MA
    Blood Cells Mol Dis; 2014 Apr; 52(4):152-60. PubMed ID: 24411920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.